Abstract
Background: The current literature is scarce as to the outcomes of COVID-19 infection in non-Hodgkin's lymphoma patients and whether immunosuppressive or chemotherapeutic agents can cause worsening of the patients’ condition during COVID-19 infection. Case presentation: Our case is a 59-year-old gentleman who presented to the Emergency Department of the Cancer Institute of Hospital das Clínicas da Universidade de São Paulo, São Paulo, Brazil on 10th May 2020 with a worsening dyspnea and chest pain which had started 3 days prior to presentation to the Emergency Department. He had a past history of non-Hodgkin's lymphoma for which he was receiving chemotherapy. Subsequent PCR testing demonstrated that our patient was SARS-CoV-2 positive. Conclusion: In this report, we show a patient with non-Hodgkin lymphoma in the middle of chemotherapy, presented a mild clinical course of COVID-19 infection.
Author supplied keywords
Cite
CITATION STYLE
Eilami, O., Lopes, M. I. B. F., Gryschek, R. C. B., & Taghipour, K. (2021). A case report of COVID-19 in a patient with non-Hodgkin’s lymphoma. BMC Infectious Diseases, 21(1). https://doi.org/10.1186/s12879-021-06472-2
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.